Literature DB >> 25013088

Variation of betaine, N,N-dimethylglycine, choline, glycerophosphorylcholine, taurine and trimethylamine-N-oxide in the plasma and urine of overweight people with type 2 diabetes over a two-year period.

Christopher J McEntyre1, Michael Lever2, Stephen T Chambers3, Peter M George4, Sandy Slow3, Jane L Elmslie5, Christopher M Florkowski5, Helen Lunt6, Jeremy D Krebs7.   

Abstract

BACKGROUND: Plasma betaine concentrations and urinary betaine excretions have high test-retest reliability. Abnormal betaine excretion is common in diabetes. We aimed to confirm the individuality of plasma betaine and urinary betaine excretion in an overweight population with type 2 diabetes and compare this with the individuality of other osmolytes, one-carbon metabolites and trimethylamine-N-oxide (TMAO), thus assessing their potential usefulness as disease markers.
METHODS: Urine and plasma were collected from overweight subjects with type 2 diabetes at four time points over a two-year period. We measured the concentrations of the osmolytes: betaine, glycerophosphorylcholine (GPC) and taurine, as well as TMAO, and the one-carbon metabolites, N,N-dimethylglycine (DMG) and free choline. Samples were measured using tandem mass spectrometry (LC-MS/MS).
RESULTS: Betaine showed a high degree of individuality (or test-retest reliability) in the plasma (index of individuality = 0.52) and urine (index of individuality = 0.45). Betaine in the plasma had positive and negative log-normal reference change values (RCVs) of 54% and -35%, respectively. The other osmolytes, taurine and GPC were more variable in the plasma of individuals compared to the urine. DMG and choline showed high individuality in the plasma and urine. TMAO was highly variable in the plasma and urine (log-normal RCVs ranging from 403% to -80% in plasma).
CONCLUSIONS: Betaine is highly individual in overweight people with diabetes. Betaine, its metabolite DMG, and precursor choline showed more reliability than the osmolytes, GPC and taurine. The low reliability of TMAO suggests that a single TMAO measurement has low diagnostic value.
© The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  N; Betaine; N-dimethylglycine; choline; coefficient of reliability; diabetes; glycerophosphorylcholine; index of individuality; reference change value; taurine; trimethylamine-N-oxide

Mesh:

Substances:

Year:  2014        PMID: 25013088     DOI: 10.1177/0004563214545346

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  25 in total

Review 1.  [Gut-heart axis : How gut bacteria influence cardiovascular diseases].

Authors:  Hendrik Bartolomaeus; Victoria McParland; Nicola Wilck
Journal:  Herz       Date:  2020-04       Impact factor: 1.443

2.  Betaine is accumulated via transient choline dehydrogenase activation during mouse oocyte meiotic maturation.

Authors:  Taylor McClatchie; Megan Meredith; Mariame O Ouédraogo; Sandy Slow; Michael Lever; Mellissa R W Mann; Steven H Zeisel; Jacquetta M Trasler; Jay M Baltz
Journal:  J Biol Chem       Date:  2017-06-29       Impact factor: 5.157

3.  Plasma trimethylamine-N-oxide and related metabolites are associated with type 2 diabetes risk in the Prevención con Dieta Mediterránea (PREDIMED) trial.

Authors:  Christopher Papandreou; Mònica Bulló; Yan Zheng; Miguel Ruiz-Canela; Edward Yu; Marta Guasch-Ferré; Estefanía Toledo; Clary Clish; Dolores Corella; Ramon Estruch; Emilio Ros; Montserrat Fitó; Fernando Arós; Miquel Fiol; José Lapetra; Lluís Serra-Majem; Enrique Gómez-Gracia; Liming Liang; Georgios A Fragkiadakis; Cristina Razquin; Frank B Hu; Jordi Salas-Salvadó
Journal:  Am J Clin Nutr       Date:  2018-07-01       Impact factor: 7.045

4.  Metabolic fingerprinting analysis of oil palm reveals a set of differentially expressed metabolites in fatal yellowing symptomatic and non-symptomatic plants.

Authors:  Jorge Candido Rodrigues-Neto; Mauro Vicentini Correia; Augusto Lopes Souto; José Antônio de Aquino Ribeiro; Letícia Rios Vieira; Manoel Teixeira Souza; Clenilson Martins Rodrigues; Patrícia Verardi Abdelnur
Journal:  Metabolomics       Date:  2018-10-11       Impact factor: 4.290

Review 5.  Trimethylamine N-oxide: breathe new life.

Authors:  Saravanan Subramaniam; Craig Fletcher
Journal:  Br J Pharmacol       Date:  2017-08-30       Impact factor: 8.739

6.  Trimethylamine-N-oxide and its biological variations in vegetarians.

Authors:  Rima Obeid; Hussain M Awwad; Markus Keller; Juergen Geisel
Journal:  Eur J Nutr       Date:  2016-08-25       Impact factor: 5.614

Review 7.  Microbiome, trimethylamine N-oxide, and cardiometabolic disease.

Authors:  W H Wilson Tang; Stanley L Hazen
Journal:  Transl Res       Date:  2016-07-18       Impact factor: 7.012

8.  Utility of Plasma Concentration of Trimethylamine N-Oxide in Predicting Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes.

Authors:  Signe A Winther; Jens C Øllgaard; Nete Tofte; Lise Tarnow; Zeneng Wang; Tarunveer S Ahluwalia; Anders Jorsal; Simone Theilade; Hans-Henrik Parving; Tine W Hansen; Stanley L Hazen; Oluf Pedersen; Peter Rossing
Journal:  Diabetes Care       Date:  2019-05-23       Impact factor: 19.112

9.  Development of plasma functionalized polypropylene wound dressing for betaine hydrochloride controlled drug delivery on diabetic wounds.

Authors:  Leila Zahedi; Pedram Ghourchi Beigi; Mojtaba Shafiee; Fatemeh Zare; Hamed Mahdikia; Majid Abdouss; Mohammad-Amin Abdollahifar; Babak Shokri
Journal:  Sci Rep       Date:  2021-05-05       Impact factor: 4.379

10.  Differential effects of oral and intravenous l-carnitine on serum lipids: is the microbiota the answer?

Authors:  Maria Dolores Sanchez-Niño; Alberto Ortiz
Journal:  Clin Kidney J       Date:  2014-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.